The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives
Abstract Cancer immunotherapy has revolutionized oncology by leveraging the immune system to combat tumors. Among various biomarkers, neoantigens and tumor mutational burden (TMB) have emerged as critical factors in tailoring personalized treatments. Neoantigens are tumor-specific peptides displayed...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2025-09-01
|
| Rangatū: | Journal of Hematology & Oncology |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s13045-025-01732-z |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|